Neuronal C/EBPβ/AEP pathway shortens life span via selective GABAnergic neuronal degeneration by FOXO repression
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The age-related cognitive decline of normal aging is exacerbated in neurodegenerative diseases including Alzheimer’s disease (AD). However, it remains unclear whether age-related cognitive regulators in AD pathologies contribute to life span. Here, we show that C/EBPβ, an Aβ and inflammatory cytokine–activated transcription factor that promotes AD pathologies via activating asparagine endopeptidase (AEP), mediates longevity in a gene dose–dependent manner in neuronal C/EBPβ transgenic mice. C/EBPβ selectively triggers inhibitory GABAnergic neuronal degeneration by repressing FOXOs and up-regulating AEP, leading to aberrant neural excitation and cognitive dysfunction. Overexpression of CEBP-2 or LGMN-1 (AEP) in Caenorhabditis elegans neurons but not muscle stimulates neural excitation and shortens life span. CEBP-2 or LGMN-1 reduces daf-2 mutant–elongated life span and diminishes daf-16 –induced longevity. C/EBPβ and AEP are lower in humans with extended longevity and inversely correlated with REST/FOXO1. These findings demonstrate a conserved mechanism of aging that couples pathological cognitive decline to life span by the neuronal C/EBPβ/AEP pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1. Neuronal C/EBPβ overexpression elicits short life span, associated with behavioral impairments in Thy1-C/EBPβ Tg mice, related to fig. S1. (A) Human C/EBPβ overexpression in neurons shortens life span. C/EBPβ Tg strain of origin: C57BL/6; P < 0.0001, log-rank test; ***P < 0.001. (B) C/EBPβ knockdown extends life span. C/EBPβ+/− strain of origin: 129S1/Sv-Oca2+ Tyr+ Kitl+; P < 0.0001, log-rank test; ***P < 0.001. (C) Left: Images from PET-CT scanning of 18F-FDG uptake in 6-month-old Thy1-C/EBPβ Tg, C/EBPβ+/−, and age-matched WT littermates. Right: Standardized uptake value (SUV) at increasing time intervals after injection of 18F-FDG. Means ± SEM; n = 3 mice per group; **P < 0.01; Mann-Whitney U test. (D) Seizure duration after administration of PTZ (35 mg kg−1). Control (WT), n = 6; C/EBPβ Tg, n = 6; C/EBPβ+/−, n = 6 mice. *P < 0.05 and **P < 0.01; Mann-Whitney U test. (E) Elevated [Ca2+]i in the C/EBPβ-overexpressing hippocampal CA1. The box plots indicate first, median, and third quartiles as well as outliers. N = 196 (WT control) and 95 cells (C/EBPβ Tg) pooled from six animals each; *P = 0.043, t(289) = 2.04; two-tailed Student’s t test. (F) PPI. Means ± SEM; n = 8 mice per group; unpaired t test with Welch’s correction. (G) Open field test. Means ± SEM; n = 8 mice per group; *P < 0.05; unpaired t test with Welch’s correction. (H) FST. Means ± SEM; n = 8 mice per group; unpaired t test with Welch’s correction. (I) Sleep latency test. Means ± SEM; n = 8 mice per group; *P < 0.05; unpaired t test with Welch’s correction. (J and K) MWM analysis of cognitive functions. Means ± SEM; n = 8 mice per group; *P < 0.05 and **P < 0.01; unpaired t test with Welch’s correction. (L) Fear condition tests. Means ± SEM; n = 8 mice per group; *P < 0.05, and **P < 0.01; unpaired t test with Welch’s correction.](https://figures.cochat.ai/paper-figures/7ac6299393914d238c4ffe85f82b8535/neuronal-c-ebp-aep-pathway-shortens-life-span-via-selective-gabanergic-neuronal-figure-1.jpg)


![Fig. 4. Neuronal C/EBPβ represses REST and FOXO1 expression in the brain, related to figs. S5 to S7. (A and B) Rat primary neurons (DIV 12) were infected with lentivirus expressing FOXO1 or C/EBPβ, sh-FOXO1, or sh-C/EBPβ for 72 hours. Neurons were harvested for real-time PCR (A) and WB (B). Control, vector virus. (Means ± SEM; *P < 0.05 and **P < 0.01; n = 3; two-way ANOVA and Bonferroni’s post hoc test). (C) The LAP/LIP isoform ratios were calculated from quantification by immunoblots of (B). Data are represented as means ± SEM; n = 4 per group. **P < 0.01; two-way ANOVA and Bonferroni’s post hoc test. (D) Luciferase assay. Human REST and FOXO1 promoter luciferase plasmids were cotransfected into SH-SY5Y cells with C/EBPβ–green fluorescent protein (GFP) overexpression plasmid for 48 hours. The luciferase activities were calculated by using the Luciferase Reporter Assay System, which indicated the promoter activities. (Means ± SEM; **P < 0.01; n = 3; one-way ANOVA). RLU, relative light units. (E) Chromatin immunoprecipitation (ChIP) assay. ChIP assay was performed to detect the binding sites of C/EBPβ on the human REST and FOXO1 promoters. The DNA-protein cross-linking ChIP samples were immunoprecipitated with anti-C/EBPβ antibody or immunoglobulin G (IgG). After reversing cross-links, PCR was performed by using primer pairs at −1409 to −1189 (REST) or −1587 to −1357 (FOXO1) of the PCR assays that also detected each input sample. Genomic DNA samples were pulled down with anti–histone H3 and normalized by glyceraldehyde phosphate dehydrogenase (GAPDH) primers as positive control. The equal amount of input was confirmed with REST and FOXO1. (F) EMSA. Nuclear extract proteins (NE) were isolated from SH-SY5Y cells transfected with C/EBPβ-GFP for 48 hours. EMSA was used to detect the C/EBPβ binding ability on sites −1250 to −1260 (REST) or −1504 to −1495 (FOXO1) promoter [ATGTTGTAATA (REST) or TTTACTTAAC (FOXO1)], mutation probe 1 [GCGTTGTAATA (REST) or TTTACTTGGC (FOXO1)] or mutation probe 2 [(ATTTTGTAATA (REST) or TTTACTTAAT (FOXO1)], and supershift. Data are representative of three independent experiments.](https://figures.cochat.ai/paper-figures/71fdc4e95f444c9091742fb0b82036ae/neuronal-c-ebp-aep-pathway-shortens-life-span-via-selective-gabanergic-neuronal-figure-4.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of the transcription factor C/EBPβ has been found to increase with age, resulting in the activation of AEP (also known as δ-secretase) transcription and ultimately leading to excitatory neurotoxicity and a shortened lifespan.398”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [398]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Timmons, L., Court, D. L., & Fire, A. (2001) · Gene · doi:10.1016/s0378-1119(00)00579-5 · Cited by 1,843
Lin, K., Dorman, J. B., Rodan, A., & Kenyon, C. (1997) · Science · doi:10.1126/science.278.5341.1319 · Cited by 1,495
Religious Orders Study and Rush Memory and Aging Project
Bennett, D. A., Buchman, A. S., Boyle, P. A., Barnes, L. L., Wilson, R. S., & Schneider, J. A. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179939 · Cited by 1,260 · cited 1×
“The former samples were all from the Religious Orders Study (ROS) ( 56 ): three ages 70 to 80 and three ages 100+. ROS was approved by the Institutional Review Board of Rush University Medical Center.”
Self-citationLin, K., Hsin, H., Libina, N., & Kenyon, C. (2001) · Nature Genetics · doi:10.1038/88850 · Cited by 1,039
Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span
Lehtinen, M. K., Yuan, Z., Boag, P. R., Yang, Y., Villén, J., Becker, E. B. E., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.046 · Cited by 839
Broughton, S. J., Piper, M. D. W., Ikeya, T., Bass, T. M., Jacobson, J., Driege, Y., Martinez, P., Hafen, E., Withers, D. J., Leevers, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405775102 · Cited by 822
Moloney, A. M., Griffin, R. J., Timmons, S., O’Connor, R., Ravid, R., & O’Neill, C. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.002 · Cited by 764 · cited 1×
“IGF-1R and insulin receptor (IR) signalings are compromised in human AD neurons, suggestive of resistance to IGF-1R/IR signaling ( 10 ).”
The Role of C/EBP Genes in Adipocyte Differentiation
Darlington, G. J., Ross, S. E., & MacDougald, O. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30057 · Cited by 758
Epilepsy and Cognitive Impairments in Alzheimer Disease
Palop, J. J. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.15 · Cited by 684 · cited 1×
“Substantial evidence shows that loss of GABAnergic tone leads to seizures and 10 to 22% of patients with AD exhibit seizures ( 53 ), as do hAPP FAD mice, and the onset of these seizures precedes cognitive decline ( 54 ).”
Regulation of C. elegans Life-Span by Insulinlike Signaling in the Nervous System
Wolkow, C. A., Kimura, K. D., Lee, M.-S., & Ruvkun, G. (2000) · Science · doi:10.1126/science.290.5489.147 · Cited by 682
Two neurons mediate diet-restriction-induced longevity in C. elegans
Bishop, N. A., & Guarente, L. (2007) · Nature · doi:10.1038/nature05904 · Cited by 643
FOXO transcription factors: key regulators of cellular quality control
Webb, A. E., & Brunet, A. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.003 · Cited by 617
Regulation of lifespan by sensory perception in Caenorhabditis elegans
Apfeld, J., & Kenyon, C. (1999) · Nature · doi:10.1038/45544 · Cited by 573 · cited 1×
“In the nematode Caenorhabditis elegans , deletion of specific sensory or neurosecretory neurons alters life span ( 1 – 3 ), and life-span extension from reduced insulin/insulin-like growth factor (IGF)–like signaling can be reversed by restoring function specifically in neurons ( 4 ).”
Reduced IGF-1 signaling delays age-associated proteotoxicity in mice
Cohen, E., Paulsson, J. F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H. M., Holzenberger, M., Kelly, J. W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.014 · Cited by 488
An essential role for C/EBPβ in female reproduction
Sterneck, E., Tessarollo, L., & Johnson, P. F. (1997) · Genes & Development · doi:10.1101/gad.11.17.2153 · Cited by 390
Regulation of C. elegans Longevity by Specific Gustatory and Olfactory Neurons
Alcedo, J., & Kenyon, C. (2004) · Neuron · doi:10.1016/s0896-6273(03)00816-x · Cited by 388
Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
Soukas, A. A., Kane, E. A., Carr, C. E., Melo, J. A., & Ruvkun, G. (2009) · Genes & Development · doi:10.1101/gad.1775409 · Cited by 380
A cellular and regulatory map of the cholinergic nervous system of C. elegans
Pereira, L., Kratsios, P., Serrano-Saiz, E., Sheftel, H., Mayo, A. E., Hall, D. H., White, J. G., LeBoeuf, B., Garcia, L. R., Alon, U., et al. (2015) · eLife · doi:10.7554/elife.12432 · Cited by 365
In vivo imaging of C. elegans ASH neurons: cellular response and adaptation to chemical repellents
Hilliard, M. A., Apicella, A. J., Kerr, R., Suzuki, H., Bazzicalupo, P., & Schafer, W. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600493 · Cited by 336
Regulation of lifespan by neural excitation and REST
Zullo, J. M., Drake, D., Aron, L., O’Hern, P., Dhamne, S. C., Davidsohn, N., Mao, C.-A., Klein, W. H., Rotenberg, A., Bennett, D. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1647-8 · Cited by 233
Self-citationBi, D., Wen, L., Wu, Z., & Shen, Y. (2020) · Alzheimer's & Dementia · doi:10.1002/alz.12088 · Cited by 232 · cited 1×
“GABAnergic (Gamma-Aminobutyric Acid-nergic) neurons are the most important negative regulator in excitatory and inhibitory balance in aging and AD ( 26 , 27 ).”
Freude, S., Hettich, M. M., Schumann, C., Stöhr, O., Koch, L., Köhler, C., Udelhoven, M., Leeser, U., Müller, M., Kubota, N., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-132043 · Cited by 218
Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Najm, R., Jones, E. A., & Huang, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0324-6 · Cited by 183
Shavlakadze, T., Morris, M., Fang, J., Wang, S. X., Zhu, J., Zhou, W., Tse, H. W., Mondragon-Gonzalez, R., Roma, G., & Glass, D. J. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.043 · Cited by 170 · cited 1×
“Cebpb is a top hit in screens identifying candidate transcriptional regulators of aging-associated genes ( 20 ).”
MacDougald, O. A., Cornelius, P. K., Liu, R., & Lane, M. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.647 · Cited by 169
The contribution of GABAergic dysfunction to neurodevelopmental disorders
Ramamoorthi, K., & Lin, Y. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.003 · Cited by 166
A cellular and regulatory map of the GABAergic nervous system of C. elegans
Gendrel, M., Atlas, E. G., & Hobert, O. (2016) · eLife · doi:10.7554/elife.17686 · Cited by 165
Ubiquitin Ligase COP1 Suppresses Neuroinflammation by Degrading c/EBPβ in Microglia
Ndoja, A., Reja, R., Lee, S.-H., Webster, J. D., Ngu, H., Rose, C. M., Kirkpatrick, D. S., Modrusan, Z., Chen, Y.-J. J., Dugger, D. L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.011 · Cited by 159
FOTI, D. P., Iuliano, R., CHIEFARI, E. D., & Brunetti, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2720-2732.2003 · Cited by 155
Inhibition of delta-secretase improves cognitive functions in mouse models of Alzheimer’s disease
Zhang, Z., Obianyo, O., Dall, E., Du, Y., Fu, H., Liu, X., Kang, S. S., Song, M., Yu, S.-P., Cabrele, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14740 · Cited by 146 · cited 1×
“Because knocking down lgmn-1 extended the life span of the strain that overexpresses cebp-2 in neurons, we wondered whether biochemical inhibition of LGMN (legumain)-1 with its small molecular inhibitor compound #11 (C11) exerts a similar effect ( 33 ).”
Self-citationC. elegans Positive Butanone Learning, Short-term, and Long-term Associative Memory Assays
Kauffman, A., Parsons, L. R., Stein, G. M., Wills, A. A., Kaletsky, R. L., & Murphy, C. T. (2011) · Journal of Visualized Experiments · doi:10.3791/2490 · Cited by 140
Wang, Z.-H., Gong, K., Liu, X., Zhang, Z., Sun, X., Wei, Z. Z., Yu, S. P., Manfredsson, F. P., Sandoval, I. M., Johnson, P. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04120-z · Cited by 137
Self-citationC/EBPβ and C/EBPδ transcription factors: Basic biology and roles in the CNS
Pulido-Salgado, M., Vidal-Taboada, J. M., & Saura, J. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.06.003 · Cited by 127
Lu, M., Seufert, J., & Habener, J. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28349 · Cited by 126
Matsuda, T., Kido, Y., Asahara, S., Kaisho, T., Tanaka, T., Hashimoto, N., Shigeyama, Y., Takeda, A., Inoue, T., Shibutani, Y., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39721 · Cited by 122
Jinno, S., Aika, Y., Fukuda, T., & Kosaka, T. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01075-0 · Cited by 114
GABA‐mediated Ca2+ signalling in developing rat cerebellar Purkinje neurones
Eilers, J., Plant, T. D., Marandi, N., & Konnerth, A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0429c.xd · Cited by 113
Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells
Chiu, C., Lin, W., Huang, S.-Y., & Lee, Y.-H. (2004) · Genes & Development · doi:10.1101/gad.1213104 · Cited by 105
Chen, S.-S., Chen, J.-F., Johnson, P. F., Muppala, V., & Lee, Y.-H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.19.7292-7299.2000 · Cited by 101
Adult-Onset Epilepsy in Presymptomatic Alzheimer’s Disease: A Retrospective Study
DiFrancesco, J. C., Tremolizzo, L., Polonia, V., Giussani, G., Bianchi, E., Franchi, C., Nobili, A., Appollonio, I., Beghi, E., & Ferrarese, C. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170392 · Cited by 81
Cortés‐Canteli, M., Luna‐Medina, R., Sanz-SanCristóbal, M., Alvarez, A. M., Santos, Á., & Pérez‐Castillo, A. (2008) · Journal of Cell Science · doi:10.1242/jcs.025031 · Cited by 72
The C. elegans CCAAT-Enhancer-Binding Protein Gamma Is Required for Surveillance Immunity
Reddy, K. C., Dunbar, T. L., Nargund, A. M., Haynes, C. M., & Troemel, E. R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.055 · Cited by 56
Emerging Role of C/EBPβ and Epigenetic DNA Methylation in Ageing
Niehrs, C., & Calkhoven, C. F. (2020) · Trends in Genetics · doi:10.1016/j.tig.2019.11.005 · Cited by 54
Strohmeyer, R., Shelton, J. R., Lougheed, C., & Breitkopf, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086617 · Cited by 53
Identification of neuronal target genes for CCAAT/Enhancer Binding Proteins
Kfoury, N., & Kapatos, G. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.11.004 · Cited by 52
Daf-2 Signaling Modifies Mutant SOD1 Toxicity in C. elegans
Boccitto, M., Lamitina, T., & Kalb, R. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033494 · Cited by 48
Deficiency in mTORC1‐controlled C/EBPβ‐mRNA translation improves metabolic health in mice
Zidek, L. M., Ackermann, T., Hartleben, G., Eichwald, S., Kortman, G., Kiehntopf, M., Leutz, A., Sonenberg, N., Wang, Z., von Maltzahn, J., et al. (2015) · EMBO Reports · doi:10.15252/embr.201439837 · Cited by 48
Self-citationModulation of inducible nitric oxide synthase expression by sumoylation
Akar, C. A., & Feinstein, D. L. (2009) · Journal of Neuroinflammation · doi:10.1186/1742-2094-6-12 · Cited by 46
Neuronal functions of FOXO/DAF-16
Kim, S. Y., & Webb, A. E. (2016) · Nutrition and Healthy Aging · doi:10.3233/nha-160009 · Cited by 43
Impaired DNA demethylation of C/EBP sites causes premature aging
Schäfer, A., Mekker, B., Mallick, M., Vastolo, V., Karaulanov, E., Sebastian, D., von der Lippen, C., Epe, B., Downes, D. J., Scholz, C., et al. (2018) · Genes & Development · doi:10.1101/gad.311969.118 · Cited by 43
Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis
Bégay, V., Smink, J. J., Loddenkemper, C., Zimmermann, K., Rudolph, C., Scheller, M., Steinemann, D., Leser, U., Schlegelberger, B., Stein, H., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1215-5 · Cited by 40
Role of C/EBPβ Transcription Factor in Adult Hippocampal Neurogenesis
Cortes-Canteli, M., Aguilar-Morante, D., Sanz-SanCristobal, M., Megias, D., Santos, A., & Perez-Castillo, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024842 · Cited by 37
Reduced expression of C/EBPβ-LIP extends health and lifespan in mice
Müller, C., Zidek, L. M., Ackermann, T., de Jong, T. V., Liu, P., Kliche, V., Zaini, M. A., Kortman, G., Harkema, L., Verbeek, D. S., et al. (2018) · eLife · doi:10.7554/elife.34985 · Cited by 36
Self-citationXu, X.-Y., Hu, J., Wu, M., Wang, L., & Fang, N. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.10.106 · Cited by 34
Insulin Inhibits Liver Expression of the CCAAT/Enhancer-Binding Protein β
Bosch, F., Sabater, J., & Valera, A. (1995) · Diabetes · doi:10.2337/diab.44.3.267 · Cited by 31
Multiphoton Excitation of Fluorescent ProbesPreprint
Xu, C., & Zipfel, W. R. (2015) · Cold Spring Harbor Protocols · doi:10.1101/pdb.top086116 · Cited by 25
The Aging GABAergic System and Its Nutritional Support
Mills, D. J. (2021) · Journal of Nutrition and Metabolism · doi:10.1155/2021/6655064 · Cited by 24
Wu, Z., Liu, X., Cheng, L., & Ye, K. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03270-7 · Cited by 17
Self-citationTang, Y., Xiong, K., Shen, M., Mu, Y., Li, K., & Liu, H. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2308-8 · Cited by 16
Suppression of FoxO1 Activity by Long-Chain Fatty Acyl Analogs
Zatara, G., Hertz, R., Shaked, M., Mayorek, N., Morad, E., Grad, E., Cahan, A., Danenberg, H. D., Unterman, T. G., & Bar‐Tana, J. (2011) · Diabetes · doi:10.2337/db11-0248 · Cited by 13
Cited by
Dietary regulation in health and disease
Wu, Q., Gao, Z.-J., Yu, X., & Wang, P. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01104-w · Cited by 176
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Self-citationXia, Y., Xiao, Y., Wang, Z.-H., Liu, X., Alam, A. M., Haran, J. P., McCormick, B. A., Shu, X., Wang, X., & Ye, K. (2023) · Nature Communications · doi:10.1038/s41467-023-41283-w · Cited by 108
Self-citationHe, W., Zhang, S., Qi, Z., & Liu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107201 · Cited by 33
C/ EBPβ : A transcription factor associated with the irreversible progression of Alzheimer's disease
Yao, Q., Long, C., Yi, P., Zhang, G., Wan, W., Rao, X., Ying, J., Liang, W., & Hua, F. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14721 · Cited by 29
Metadata
- Authors
- Xia, Y., Qadota, H., Wang, Z.-H., Liu, P., Liu, X., Ye, K. X., Matheny, C. J., Berglund, K., Yu, S. P., Drake, D., Bennett, D. A., Wang, X.-C., Yankner, B. A., Benian, G. M., & Ye, K.
- Affiliations
- Emory University (US)
- Harvard University (US)
- Rush University Medical Center (US)
- Department of Pathophysiology, Key Laboratory of Ministry of Education of Neurological Diseases, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Corresponding author
- Ye, Keqiang
- ORCID
- Venue
- Science Advances
- Published
- 2022-04
- Volume
- 8
- Issue
- 13
- Pages
- eabj8658-eabj8658
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC8967231
- OpenAlex
- W4220755159
- Cited by
- 46
- References
- 64
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 3 · 2022: 2
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1s10od021773-01a1, P40OD010440, UL1TR002378)
- National Institute on Aging (R01AG017917, R01AG065177, R01AG015819, P30AG010161, U01AG061356, R01AG069042, P30AG066511, P30AG072975)
- National Institute of Neurological Disorders and Stroke (P30NS055077)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- C/EBPβ, asparaginyl endopeptidase, excitotoxicity, aging, lifespan, Alzheimer's disease, age-related cognitive decline, daf-2, DAF-16, Caenorhabditis elegans neurons, transgenic mice, longevity
- MeSH terms
- Animals, Longevity, Neurons, Caenorhabditis elegans, Caenorhabditis elegans Proteins, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.